The statistical analysis of a clinical trial when a protocol amendment changed the inclusion criteria
Open Access
- 8 April 2008
- journal article
- Published by Springer Science and Business Media LLC in BMC Medical Research Methodology
- Vol. 8 (1), 16
- https://doi.org/10.1186/1471-2288-8-16
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trialBritish Journal of Dermatology, 2006
- Faculty Opinions recommendation of Evaluation of experiments with adaptive interim analyses.Published by H1 Connect ,2006
- Estimation in flexible two stage designsStatistics in Medicine, 2005
- Inference for Clinical Trials with Some Protocol AmendmentsJournal of Biopharmaceutical Statistics, 2005
- A systematic comparison of methods for combining p-values from independent testsComputational Statistics & Data Analysis, 2004
- A general statistical principle for changing a design any time during the course of a trialStatistics in Medicine, 2004
- Statistical Quality Control in Clinical TrialsControlled Clinical Trials, 1999
- ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group.1999
- On the Power of Fisher's Combination Test for Two Stage Sampling in the Presence of Nuisance ParametersBiometrical Journal, 1996
- Evaluation of Experiments with Adaptive Interim AnalysesBiometrics, 1994